Wordt geladen...
Emerging therapeutic options for myelofibrosis: a Canadian perspective
Myelofibrosis (MF) is a clonal stem cell disorder characterized by cytopenias, splenomegaly, marrow fibrosis, and systemic symptoms due to elevated inflammatory cytokines. MF is associated with decreased survival. The quality of life of patients with MF is similar to other advanced malignancies. All...
Bewaard in:
| Hoofdauteurs: | , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
e-Century Publishing Corporation
2012
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3484412/ https://ncbi.nlm.nih.gov/pubmed/23119228 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|